Equity Research Medical Instruments & Supplies

Should You Buy Stevanato Group S.p.A. Stock in 2026?

By CirclFi Research Team · · Updated · 9/13 models active

According to the CirclFi Deep Alpha Valuation Engine, Stevanato Group S.p.A. (STVN) is rated as a strong fundamental performer with a QOC score of 7.7/10. Trading at $21.54, our valuation engine evaluates whether the market price reflects the company's underlying earnings power.

The short answer: 1 of 9 CirclFi valuation models project upside for Stevanato Group S.p.A. (STVN) at $21.54 — the model consensus leans bearish, with a Quality Score of 7.7/10 and Value-Trap risk of 24/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • 8 of 9 models suggest overvaluation — majority bearish
  • Quality Score: 7.7/10 — Strong — above-average quality
  • Value Trap Risk: 24/100 — Minimal — healthy fundamentals
  • Fair Value Range: $1.05 – $28.25 (2589% spread)

Bullish Models

1 / 9

Bearish Models

8 / 9

Quality Score

7.7 /10

Strong — above-average quality

Value Trap Risk

24 /100
Minimal

Minimal — healthy fundamentals

Model Consensus

9 /13
Active Models

Avg. confidence: 45%

What Is the Investment Case for Stevanato Group S.p.A. (STVN) in 2026?

What Is the Bull Case vs the Bear Case for Stevanato Group S.p.A. (STVN)?

Bull case versus bear case for Stevanato Group S.p.A. (STVN) at $21.54, derived from 9 active CirclFi valuation models on 2026-09-15.
Bull case — $28.25 target (+31.2%) Bear case — $1.05 target (-95.1%)
According to the CirclFi Quality of Company (QOC) framework, Stevanato Group S.p.A.'s score of 7.7/10 reflects durable competitive advantages that should sustain earnings power through market cycles. According to the CirclFi Deep Alpha Valuation Engine, the Markov DDM model sees the stock as overvalued with a fair value of $1.05 (-95.1%), suggesting that the market price embeds overly optimistic growth assumptions.
According to the CirclFi Deep Alpha Valuation Engine, the Regime Cross-Sectional model targets a fair value of $28.25 (+31.2%), anchoring the bull case with a methodology that provides a differentiated analytical lens. According to the CirclFi Deep Alpha Valuation Engine, model disagreement is high with a +126.3% spread between the most bullish and bearish models, signaling elevated analytical uncertainty.

How Does STVN Compare to Its Medical Instruments & Supplies Peers?

ATRC AtriCure, Inc.
7.8
MDLN Medline Inc.
7.7
EMBC Embecta Corp.
7.8
WRBY Warby Parker Inc.
7.6
RGEN Repligen Corporation
8.0
ICUI ICU Medical, Inc.
7.5
MMED MiniMed Group, Inc.
6.5
LUCY Lucyd, Inc
5.5

Valuation data pages: ATRC · MDLN · EMBC · WRBY · RGEN · ICUI · MMED · LUCY · LMAT · ISRG · RMD

See full Medical Instruments & Supplies rankings →

Which Other Stocks Score Like STVN on Quality?

Closest companies to STVN’s Quality of Company score of 7.7/10, across all industries.

Why Do CirclFi’s 9 Models Disagree on STVN?

Spread

2589%

Fair Value Range

$1.05 – $28.25

A 2589% spread signals high uncertainty. The investment outcome depends heavily on which scenario plays out.

Most Bullish

Regime Cross

$28.25 (+31.2%)

Most Bearish

Markov DDM

$1.05 (-95.1%)

What Are the Biggest Risks of Buying STVN Stock?

Model Disagreement

2589% spread signals high variance in projections.

Bearish Consensus

8/9 models suggest overvaluation.

Macro/Sector Risk

Medical Instruments & Supplies headwinds could affect earnings trajectory.

Model Limitations

Backward-looking models cannot predict disruptions.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View STVN Data Page →

So Is Stevanato Group S.p.A. (STVN) Worth Buying in 2026?

Our valuation engine sends a clear cautionary signal on Stevanato Group S.p.A. at $21.54. 8/9 models flag overvaluation, median fair value sits at $8.75 (-59.4%), and the risk-reward profile appears unfavorable. Quality at 7.7/10 is the one bright spot, but premium quality at the wrong price can still destroy returns. This is a stock where patience — or avoidance — may be the optimal strategy.

These are quantitative model outputs, not investment recommendations. Stevanato Group S.p.A.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

What Else Do Investors Ask About STVN Stock?

Should I buy STVN stock right now?

Based on CirclFi's multi-model analysis, 1 of 9 models see upside for STVN at $21.54. The models are divided, which means the investment case depends heavily on your assumptions about Stevanato Group S.p.A.'s future. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in Stevanato Group S.p.A.?

Key risks include: wide model disagreement (2589% spread), signaling high uncertainty; general market and sector-specific risks affecting Medical Instruments & Supplies companies. Always diversify and consult a financial advisor.

How does STVN compare to its competitors?

Among Medical Instruments & Supplies peers, STVN holds a Quality Score of 7.7/10. Comparable companies include ATRC (QOC 7.8), MDLN (QOC 7.7), EMBC (QOC 7.8). The relative ranking helps investors identify whether STVN offers better fundamental quality than alternatives in the same sector.

Is STVN a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. STVN's Quality Score of 7.7/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.

What price should I buy STVN at?

CirclFi does not provide target buy prices or price alerts. However, our 9 active models produce fair value estimates ranging from $1.05 to $28.25. At $21.54, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for STVN.

View STVN Data Page Full Terminal — $39/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →